7) Therapeutics
Abstract
Cutaneous and Ocular: Focuses on therapeutic strategies to effectively minimize injuries to dermal and ocular tissues resulting from exposure to chemical warfare agents (CWAs). Involves the development of effective practical field and clinic management strategies and physical and pharmacological interventions to treat the injury processes. This work is designed to support eventual FDA licensure of new non-licensed compounds or new indications for licensed products for use in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2011
- Source ID
- 78098545e5197937ae4b28d755502dd1